海尔生物：累计回购约238万股

Group 1 - Company Haier Biomedical announced a share buyback of approximately 2.38 million shares, representing 0.7474% of its total share capital of about 318 million shares, with a total expenditure of approximately 77.12 million RMB [1] - The highest and lowest prices for the repurchased shares were 34.69 RMB and 29.86 RMB per share, respectively [1] - For the fiscal year 2024, the revenue composition of Haier Biomedical is 99.57% from medical devices and 0.43% from other businesses [1] Group 2 - The current market capitalization of Haier Biomedical is 10.5 billion RMB [2]